Page last updated: 2024-09-03

ilomastat and N-(2-aminophenyl)-2-pyrazinecarboxamide

ilomastat has been researched along with N-(2-aminophenyl)-2-pyrazinecarboxamide in 1 studies

Compound Research Comparison

Studies
(ilomastat)
Trials
(ilomastat)
Recent Studies (post-2010)
(ilomastat)
Studies
(N-(2-aminophenyl)-2-pyrazinecarboxamide)
Trials
(N-(2-aminophenyl)-2-pyrazinecarboxamide)
Recent Studies (post-2010) (N-(2-aminophenyl)-2-pyrazinecarboxamide)
103045505

Protein Interaction Comparison

ProteinTaxonomyilomastat (IC50)N-(2-aminophenyl)-2-pyrazinecarboxamide (IC50)
Histone deacetylase 3Homo sapiens (human)0.3813
Histone deacetylase 1Homo sapiens (human)2.151
Histone deacetylase 2Homo sapiens (human)2.281
Histone deacetylase 8Homo sapiens (human)2.85
Histone deacetylase 6Homo sapiens (human)3.415

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for ilomastat and N-(2-aminophenyl)-2-pyrazinecarboxamide

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023